219 related articles for article (PubMed ID: 23349715)
41. Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease.
Wahrle SE; Jiang H; Parsadanian M; Hartman RE; Bales KR; Paul SM; Holtzman DM
J Biol Chem; 2005 Dec; 280(52):43236-42. PubMed ID: 16207708
[TBL] [Abstract][Full Text] [Related]
42. Skeletal muscle as a target of LXR agonist after long-term treatment: focus on lipid homeostasis.
Archer A; Laurencikiene J; Ahmed O; Steffensen KR; Parini P; Gustafsson JÅ; Korach-André M
Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E494-502. PubMed ID: 24368671
[TBL] [Abstract][Full Text] [Related]
43. Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.
Tsui KH; Chung LC; Feng TH; Lee TY; Chang PL; Chen WT; Juang HH
Prostate; 2015 May; 75(6):603-15. PubMed ID: 25560459
[TBL] [Abstract][Full Text] [Related]
44. ATP-binding cassette transporter A1: from metabolism to neurodegeneration.
Koldamova R; Fitz NF; Lefterov I
Neurobiol Dis; 2014 Dec; 72 Pt A():13-21. PubMed ID: 24844148
[TBL] [Abstract][Full Text] [Related]
45. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux.
Abildayeva K; Jansen PJ; Hirsch-Reinshagen V; Bloks VW; Bakker AH; Ramaekers FC; de Vente J; Groen AK; Wellington CL; Kuipers F; Mulder M
J Biol Chem; 2006 May; 281(18):12799-808. PubMed ID: 16524875
[TBL] [Abstract][Full Text] [Related]
46. LXRβ activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile.
Hu X; Steffensen KR; Jiang ZY; Parini P; Gustafsson JÅ; Gåfvels M; Eggertsen G
J Intern Med; 2012 Nov; 272(5):452-64. PubMed ID: 22329358
[TBL] [Abstract][Full Text] [Related]
47. Simultaneous activation of the liver X receptors (LXRα and LXRβ) drives murine collagen-induced arthritis disease pathology.
Asquith DL; Miller AM; Reilly J; Kerr S; Welsh P; Sattar N; McInnes IB
Ann Rheum Dis; 2011 Dec; 70(12):2225-8. PubMed ID: 21859686
[TBL] [Abstract][Full Text] [Related]
48. A novel role for c-Jun N-terminal kinase and phosphoinositide 3-kinase in the liver X receptor-mediated induction of macrophage gene expression.
Huwait EA; Greenow KR; Singh NN; Ramji DP
Cell Signal; 2011 Mar; 23(3):542-9. PubMed ID: 21070853
[TBL] [Abstract][Full Text] [Related]
49. LXR activation protects hippocampal microvasculature in very old triple transgenic mouse model of Alzheimer's disease.
Sandoval-Hernández AG; Restrepo A; Cardona-Gómez GP; Arboleda G
Neurosci Lett; 2016 May; 621():15-21. PubMed ID: 27057732
[TBL] [Abstract][Full Text] [Related]
50. Both liver-X receptor (LXR) isoforms control energy expenditure by regulating brown adipose tissue activity.
Korach-André M; Archer A; Barros RP; Parini P; Gustafsson JÅ
Proc Natl Acad Sci U S A; 2011 Jan; 108(1):403-8. PubMed ID: 21173252
[TBL] [Abstract][Full Text] [Related]
51. microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain.
Kim J; Yoon H; Horie T; Burchett JM; Restivo JL; Rotllan N; Ramírez CM; Verghese PB; Ihara M; Hoe HS; Esau C; Fernández-Hernando C; Holtzman DM; Cirrito JR; Ono K; Kim J
J Neurosci; 2015 Nov; 35(44):14717-26. PubMed ID: 26538644
[TBL] [Abstract][Full Text] [Related]
52. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
Kratzer A; Buchebner M; Pfeifer T; Becker TM; Uray G; Miyazaki M; Miyazaki-Anzai S; Ebner B; Chandak PG; Kadam RS; Calayir E; Rathke N; Ahammer H; Radovic B; Trauner M; Hoefler G; Kompella UB; Fauler G; Levi M; Levak-Frank S; Kostner GM; Kratky D
J Lipid Res; 2009 Feb; 50(2):312-26. PubMed ID: 18812595
[TBL] [Abstract][Full Text] [Related]
53. The effects of LXR agonist GW3965 on vascular reactivity and inflammation in hypertensive rat aorta.
Han S; Bal NB; Sadi G; Usanmaz SE; Uludag MO; Demirel-Yilmaz E
Life Sci; 2018 Nov; 213():287-293. PubMed ID: 30366037
[TBL] [Abstract][Full Text] [Related]
54. Liver X receptor agonist prevents the evolution of collagen-induced arthritis in mice.
Park MC; Kwon YJ; Chung SJ; Park YB; Lee SK
Rheumatology (Oxford); 2010 May; 49(5):882-90. PubMed ID: 20159908
[TBL] [Abstract][Full Text] [Related]
55. Enhanced neurofibrillary tangle formation, cerebral atrophy, and cognitive deficits induced by repetitive mild brain injury in a transgenic tauopathy mouse model.
Yoshiyama Y; Uryu K; Higuchi M; Longhi L; Hoover R; Fujimoto S; McIntosh T; Lee VM; Trojanowski JQ
J Neurotrauma; 2005 Oct; 22(10):1134-41. PubMed ID: 16238489
[TBL] [Abstract][Full Text] [Related]
56. Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke.
Morales JR; Ballesteros I; Deniz JM; Hurtado O; Vivancos J; Nombela F; Lizasoain I; Castrillo A; Moro MA
Circulation; 2008 Sep; 118(14):1450-9. PubMed ID: 18794391
[TBL] [Abstract][Full Text] [Related]
57. Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion.
Sun Y; Yao J; Kim TW; Tall AR
J Biol Chem; 2003 Jul; 278(30):27688-94. PubMed ID: 12754201
[TBL] [Abstract][Full Text] [Related]
58. Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis.
Zhang XQ; Even-Or O; Xu X; van Rosmalen M; Lim L; Gadde S; Farokhzad OC; Fisher EA
Adv Healthc Mater; 2015 Jan; 4(2):228-36. PubMed ID: 25156796
[TBL] [Abstract][Full Text] [Related]
59. Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.
Hartman RE; Laurer H; Longhi L; Bales KR; Paul SM; McIntosh TK; Holtzman DM
J Neurosci; 2002 Dec; 22(23):10083-7. PubMed ID: 12451108
[TBL] [Abstract][Full Text] [Related]
60. Liver X receptor activation enhances blood-brain barrier integrity in the ischemic brain and increases the abundance of ATP-binding cassette transporters ABCB1 and ABCC1 on brain capillary cells.
ElAli A; Hermann DM
Brain Pathol; 2012 Mar; 22(2):175-87. PubMed ID: 21767321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]